Batu Biologics files IP for immune modulator

Batu Biologics Files Patent on Blood Derived Anti-Cancer Immunomodulator

Cancer Angiogenesis Vaccine Company Expands its Therapeutic Pipeline

Batu Biologics announced today filing of a patent application covering a recent finding by the company regarding ability to stimulate innate immune system through products that are coaxed out of white blood cells by stimulation with non-toxic agents.

Read the full article at